Literature DB >> 16882879

Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia.

Danyan Mao1, Robert P Yasuda, Hong Fan, Barry B Wolfe, Kenneth J Kellar.   

Abstract

Nicotinic cholinergic receptors (nAChRs) are present in ganglia in the peripheral nervous system. In autonomic ganglia, they are responsible for fast synaptic transmission, whereas in the sensory ganglia and sensory neurons, they may be involved in modulation of neurotransmission. The present study measured nAChRs in several rat autonomic ganglia: the superior cervical ganglia (SCG), sensory nodose ganglia, stellate ganglia, and pelvic ganglia. The densities of the heteromeric nAChRs determined by receptor binding assay in those four ganglia are 481, 45, 9, and 11 fmol/mg protein, respectively. Immunoprecipitation studies with subunit-specific antibodies showed that a majority of the nAChRs in the SCG and nodose ganglia contain the alpha3 and beta4 subunits, but a significant percentage of the nAChRs in these ganglia also contain alpha5 and beta2 subunits. A small percentage of the nAChRs in nodose ganglia also contain alpha2 and alpha4 subunits. Sequential immunoprecipitation assays indicated that in the SCG, all alpha5 subunits are associated with alpha3 and beta4 subunits, forming the mixed heteromeric alpha3beta4alpha5 subtype. A receptor composed of alpha3, beta2, and beta4 subunits in the SCG was also detected. In rat SCG, we found the following distribution of nAChRs subtypes: 55 to 60% simple alpha3beta4 subtype, 25 to 30% alpha3beta4alpha5 subtype, and 10 to 15% alpha3beta4beta2 subtype. These findings indicate that the nAChRs in SCG and nodose ganglia are heterogeneous, which suggests that different receptor subtypes may play different roles in these ganglia or may be activated under different conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882879     DOI: 10.1124/mol.106.027458

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  42 in total

Review 1.  α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.

Authors:  Hartmut Cuny; Rilei Yu; Han-Shen Tae; Shiva N Kompella; David J Adams
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

2.  Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.

Authors:  Erin E Meyers; Esteban C Loetz; Michael J Marks
Journal:  Pharmacol Biochem Behav       Date:  2015-01-03       Impact factor: 3.533

3.  α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Mick'l Scadden; Joanna Gajewiak; Sean Christensen; Jon Lindstrom; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2012-08-22       Impact factor: 4.436

4.  Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors.

Authors:  Anne Tammimäki; Penelope Herder; Ping Li; Caroline Esch; James R Laughlin; Gustav Akk; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2012-07-20       Impact factor: 5.250

5.  Cholinergic chemosensory cells in the auditory tube.

Authors:  G Krasteva; P Hartmann; T Papadakis; M Bodenbenner; L Wessels; E Weihe; B Schütz; A C Langheinrich; V Chubanov; T Gudermann; I Ibanez-Tallon; W Kummer
Journal:  Histochem Cell Biol       Date:  2012-01-20       Impact factor: 4.304

6.  Endogenously expressed muscarinic receptors in HEK293 cells augment up-regulation of stably expressed α4β2 nicotinic receptors.

Authors:  Gregory P Hussmann; Robert P Yasuda; Yingxian Xiao; Barry B Wolfe; Kenneth J Kellar
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 7.  Targeting peripheral afferent nerve terminals for cough and dyspnea.

Authors:  Yukiko Muroi; Bradley J Undem
Journal:  Curr Opin Pharmacol       Date:  2011-06-24       Impact factor: 5.547

8.  α4β2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion.

Authors:  Petra Scholze; Anna Ciuraszkiewicz; Florian Groessl; Avi Orr-Urtreger; J Michael McIntosh; Sigismund Huck
Journal:  Dev Neurobiol       Date:  2011-05       Impact factor: 3.964

9.  Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5.

Authors:  Jen C Wang; Carlos Cruchaga; Nancy L Saccone; Sarah Bertelsen; Pengyuan Liu; John P Budde; Weimin Duan; Louis Fox; Richard A Grucza; Jason Kern; Kevin Mayo; Oliver Reyes; John Rice; Scott F Saccone; Noah Spiegel; Joseph H Steinbach; Jerry A Stitzel; Marshall W Anderson; Ming You; Victoria L Stevens; Laura J Bierut; Alison M Goate
Journal:  Hum Mol Genet       Date:  2009-05-14       Impact factor: 6.150

Review 10.  Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors:  Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal:  AAPS J       Date:  2009-03-12       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.